Correction: Ly et al. Inhibitory Effect of Etravirine, a Non-Nucleoside Reverse Transcriptase Inhibitor, via Anterior Gradient Protein 2 Homolog Degradation Against Ovarian Cancer Metastasis. Int. J. Mol. Sci. 2022, 23, 944
20260 citationsJournal Articlegold Open Access
Field-Weighted Citation Impact: 0.00
Correction: Ly et al. Inhibitory Effect of Etravirine, a Non-Nucleoside Reverse Transcriptase Inhibitor, via Anterior Gradient Protein 2 Homolog Degradation Against Ovarian Cancer Metastasis. Int. J. Mol. Sci. 2022, 23, 944 | Researchclopedia